Huaxia Eye Hospital Group Co.,Ltd. (SHE:301267)
China flag China · Delayed Price · Currency is CNY
16.19
-0.05 (-0.31%)
At close: Aug 26, 2026

Huaxia Eye Hospital Group Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
462.64440.65428.64665.93513.82454.92
Depreciation & Amortization
322.34322.34309.4274.36274.11265.64
Other Amortization
79.6479.6468.9458.549.0550.55
Loss (Gain) From Sale of Assets
-2.46-2.46-3.49-11.28-1.85-0.1
Asset Writedown & Restructuring Costs
7.67.612.036.150.461.88
Loss (Gain) From Sale of Investments
-37.3-37.3-65.76-87.46-14.5-8.73
Provision & Write-off of Bad Debts
5.085.0811.8611.313.54.36
Other Operating Activities
96.4342.7446.7950.9634.5338.05
Change in Accounts Receivable
19.6619.66330.57-61.85-69.24-12.08
Change in Inventory
-7.92-7.9256.96-33.06-31.23-18.74
Change in Accounts Payable
18.6918.69-363.65108.834.0112.95
Change in Other Net Operating Assets
----0.775.16
Operating Cash Flow
943.26867.58820.3961.24769.98798.02
Operating Cash Flow Growth
8.67%5.76%-14.66%24.84%-3.51%35.11%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-205.53-231.99-279.59-448.43-235.31-173.63
Sale of Property, Plant & Equipment
3.893.812.371.723.561.79
Cash Acquisitions
-298.32-301.15-421.411.82-10.31-
Divestitures
--1.5628.55--
Investment in Securities
-597.53-608.06-132.842,247-2,795-2.02
Other Investing Activities
867.2561.1682.4278.21-6.11
Investing Cash Flow
-230.24-1,076-747.51,909-3,037-167.74

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Long-Term Debt Issued
-60--26.13-
Long-Term Debt Repaid
--480.59-195.04-144.66-143.14-122.43
Net Debt Issued (Repaid)
-450.64-420.59-195.04-144.66-117.01-122.43
Issuance of Common Stock
---2.13,053-
Repurchase of Common Stock
-1.37-1.37-199.65---
Common Dividends Paid
-261.58-258.07-91.71-156.8--0.16
Other Financing Activities
-70.38-88.12-19.75-5.13-284.65-57.99
Financing Cash Flow
-783.98-768.15-506.15-304.492,651-180.58

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Cash Flow
-70.95-976.8-433.362,566384.16449.69

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
737.73635.59540.71512.81534.68624.38
Free Cash Flow Growth
20.48%17.55%5.44%-4.09%-14.37%46.11%
Free Cash Flow Margin
17.58%15.36%13.43%12.78%16.54%20.38%
Free Cash Flow Per Share
0.880.760.640.610.700.83
Levered Free Cash Flow
855.03552.62464.23425.75447.72475.76
Unlevered Free Cash Flow
884.23581.97492.43449.53471.7499.27

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Interest Paid
2.922.920.410.520.5-
Cash Income Tax Paid
227.43226.28258.37200.68170.18173.68
Change in Working Capital
9.289.2811.88-7.24-89.12-8.55